For the Inventor, By the Inventor

Enter assignee name

North Chicago, IL, United States of America

Abbvie Inc.

USPTO Granted Patents = 823

CIPO Patents = 57

EPO Patents = 206

Trademarks = 52

Forward Citations = 6,873

Loading Chart...

Loading Chart...

1,270 inventors (with patents filed for the assignee):

Andrew J Souers (50 out of 63 patents)

Chung-Ming Hsieh (42 out of 46 patents)

Zhi-Fu Tao (39 out of 45 patents)

4. Charles W Hutchins (38 out of 69 patents)

5. Ahmed A Othman (37 out of 37 patents)

6. Le Wang (37 out of 49 patents)

7. Mohamed-Eslam F Mohamed (36 out of 36 patents)

8. Ben Klünder (35 out of 35 patents)

9. Dachun Liu (31 out of 39 patents)

10. Tariq Ghayur (31 out of 38 patents)

11. Xilu Wang (31 out of 52 patents)

12. John K Pratt (31 out of 55 patents)

13. George A Doherty (29 out of 53 patents)

14. Todd M Hansen (29 out of 32 patents)

15. Steven Elmore (29 out of 54 patents)

Core Competencies:

Anti-Hemojuvelin Antibodies

Myelofibrosis Treatment

Pharmaceutical Formulations

Anti-IL-13 Antibodies

Bruton's Tyrosine Kinase

Cancer Treatment

Apoptosis Inducing Agents

Nicotinamide RIPK1 Inhibitors

Anti-EGFR Antibody-Drug Conjugates

Integrated Stress Pathway Modulators

Solid Pharmaceutical Formulations

Infusion Pump Technology

823 patents: Sort by Forward Citations

1. 12502420 - Clostridium botulinum Serotype A Neurotoxin (BoNT/A) Sequence Variants (2025-12-23),

2. 12365729 - Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis (2025-07-22),

3. 12365689 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2025-07-22),

4. D1082224 - Carrying vest (2025-07-08),

5. D1076063 - Infusion pump (2025-05-20),

6. D1070274 - Carrying vest (2025-04-14),

7. 12251365 - Pharmaceutical formulations for subcutaneous administration (2025-03-18),

8. D1066015 - Container cap (2025-03-11),

9. D1065814 - Carrying pack for medical device (2025-03-11),

10. 12172992 - Pyrimidines for degrading Bruton's tyrosine kinase (2024-12-24),

11. 12157776 - Anti-PAPP-A antibodies and methods of use thereof (2024-12-03),

12. 12157767 - Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography (2024-12-03),

13. 12134621 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-11-05),

14. 12129294 - Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies (2024-10-29),

15. 12122826 - Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies (2024-10-22),

AbbVie is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative therapies to improve patients' lives. With a diverse portfolio of medicines, AbbVie operates in various therapeutic areas including immunology, oncology, neuroscience, virology, and more. By leveraging its expertise and scientific advancements, AbbVie strives to address some of the world's most challenging and complex healthcare issues.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

823 Patents

#1 in North Chicago, IL

#37 in Illinois

#595 in US

#1,192 in the World

North Chicago, IL, United States of America

Abbvie Inc.

Forward Citations = 6,873

1,270 inventors:

Andrew J Souers (50 out of 63 patents)

Chung-Ming Hsieh (42 out of 46 patents)

Zhi-Fu Tao (39 out of 45 patents)

4. Charles W Hutchins (38 out of 69 patents)

5. Ahmed A Othman (37 out of 37 patents)

Please report any incorrect information to support@idiyas.com

Loading…